GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Date Action Amount Person Type
Dec 30, 2021 Buy 32 467 Smith Edward B Iii Stock Option (right to buy)
Dec 30, 2021 Sell 32 467 Smith Edward B Iii Stock Option (right to buy)
Dec 13, 2021 Buy 32 467 Smith Edward B Iii Stock Option (right to buy)
Dec 13, 2021 Buy 68 807 Ostrander William L. Stock Option (right to buy)
Jan 04, 2021 Buy 65 217 Smith Edward B Iii Stock Options
Jan 04, 2021 Sell 51 487 Ostrander William L. Stock Options
Nov 12, 2020 Sell 103 304 Smith Edward B Iii Common Stock
Aug 13, 2020 Sell 15 625 Ostrander William L. Employee Stock Option (right to buy)
Aug 13, 2020 Buy 15 625 Ostrander William L. Common Stock
Aug 13, 2020 Sell 4 440 Ostrander William L. Common Stock
Mar 12, 2020 Buy 150 000 Ostrander William L. Stock Options
Jan 02, 2020 Buy 150 000 Smith Edward B Iii Stock Options
Sep 25, 2019 Buy 75 000 Ostrander William L. Stock Options
Sep 25, 2019 Buy 0 Ostrander William L.
Jan 01, 2019 Buy 150 000 Smith Edward B Iii Stock Options
Jan 01, 2019 Buy 110 570 Rosar Ann A Stock Options
Jan 01, 2019 Buy 89 430 Rosar Ann A Common Stock
Jan 08, 2018 Buy 95 294 Smith Edward B Iii Stock Options
Jan 08, 2018 Buy 45 000 Rosar Ann A Common Stock
Jan 08, 2018 Buy 66 176 Rosar Ann A Stock Options
Jun 29, 2017 Buy 25 000 Rosar Ann A Stock Options
Apr 28, 2017 Buy 335 743 Smith Edward B Iii Common Stock
Apr 28, 2017 Buy 10 010 Smith Edward B Iii Common Stock
Feb 07, 2017 Sell 6 764 Rosar Ann A Common Stock
Jan 11, 2017 Buy 6 180 Rosar Ann A Stock Options
Jan 02, 2017 Buy 90 000 Smith Edward B Iii Stock Options
Jan 02, 2017 Buy 70 000 Rosar Ann A Common Stock
Jan 02, 2017 Buy 70 000 Rosar Ann A Stock Options
Apr 05, 2016 Buy 20 000 Rosar Ann A Stock Option
Jan 11, 2016 Buy 23 810 Smith Edward B Iii Stock Options
Jan 11, 2016 Buy 21 587 Goyal Anil K. Stock Options
Jan 11, 2016 Buy 23 810 Belsky Paul Stock Options
Jan 11, 2016 Buy 23 810 Bock Louis C Stock Options
Nov 30, 2015 Buy 70 000 Creech Timothy J Stock Options
Nov 30, 2015 Buy 0 Creech Timothy J
Mar 09, 2015 Buy 0 Dipalma Stephen J.
Jan 12, 2015 Buy 10 000 Rosar Ann A Stock Options
Jan 12, 2015 Buy 12 500 Goyal Anil K. Stock Options
Jun 11, 2014 Buy 6 483 Bock Louis C Stock Options
Jun 11, 2014 Buy 6 483 Smith Edward B Iii Stock Options
Jun 11, 2014 Buy 6 483 Belsky Paul Stock Options
May 16, 2014 Buy 1 265 Belsky Paul Common Stock
May 16, 2014 Buy 1 235 Belsky Paul Common Stock
Jan 17, 2014 Buy 10 000 Czajkowski Matthew E Stock Option
Dec 16, 2013 Buy 40 000 Goyal Anil K. Stock Options
Sep 19, 2013 Buy 21 740 Bock Louis C Option
Jul 29, 2013 Buy 697 303 Brightline Capital Management, Llc Common Stock
Jul 29, 2013 Sell 697 303 Brightline Capital Management, Llc Series A Preferred
Jul 29, 2013 Buy 51 Belsky Paul Common Stock
Jul 29, 2013 Buy 1 160 Belsky Paul Common Stock
Jul 29, 2013 Sell 1 160 Belsky Paul Series B-1 Preferred
Jul 23, 2013 Buy 697 303 Smith Edward B Iii Series A Preferred Stock
Jul 23, 2013 Buy 0 Belsky Paul Common Stock
Jul 23, 2013 Buy 1 160 Belsky Paul Series B Preferred Stock
May 15, 2013 Buy 38 364 Czajkowski Matthew E Options
Apr 29, 2013 Buy 5 435 Smith Edward B Iii Options
Apr 29, 2013 Buy 5 435 Belsky Paul Options
Apr 12, 2011 Buy 16 305 Smith Edward B Iii Options
Apr 12, 2011 Buy 16 305 Belsky Paul Options
Nov 22, 2010 Buy 5 218 Smith Edward B Iii Options
Sep 02, 2010 Buy 5 218 Belsky Paul Options
INSIDER POWER
0
Last 61 transactions
Buy: 3 541 449 | Sell: 912 550 (Shares)

Based on the 61 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 3 541 449 and sold 912 550 HTBX shares in the last 61 trades.

Click to get the best stock tips daily for free!

About Heat Biologics

Heat Biologics Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against sp... HTBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT